A Study on cellular requirements for apoptotic cell death of activated T cells in EBV infection
A Study on cellular requirements for apoptotic cell death of activated T cells in EBV infection
批准号:
05454284
负责人:
MIYAWAKI Toshio
金额:
$3.01万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994
中文摘要
我们使用EB病毒诱导的传染性单核细胞增多症(IM)作为激活T细胞死亡的模型,以阐明病毒感染通过激活诱导T细胞死亡的细胞要求。研究结果如下:1)急性IM患者活化的T细胞和正常人的记忆T细胞均表达CD45RO和Fas抗原,可介导细胞凋亡。与记忆T细胞不同,IM中活化的T细胞在体外简单孵育后容易发生细胞凋亡。通过IM细胞免疫小鼠,我们获得了一种新的小鼠单抗,命名为IMN3.1,它被标记为与易凋亡的T细胞反应。对IMN3.1抗原的分子克隆正在进行中。2)IM中活化的T细胞似乎支持其对凋亡的敏感性,但缺乏具有预防细胞凋亡作用的Bcl2的表达。在寿命较短的粒细胞和单核细胞上可见少量或不表达Bcl2。重要的发现是抗Fas抗体可加速粒细胞和单核细胞的凋亡。这些观察表明,Fas抗原/配体系统可能在解决炎症和免疫反应中发挥关键作用。3)p53癌基因突变被认为是导致人类恶性肿瘤发生的原因。IM患者活化的T细胞虽易发生凋亡,但未见P53的表达。电离辐射可诱导全人群外周血淋巴细胞P53蛋白表达,并伴有明显的细胞凋亡。然而,我们发现淋巴细胞亚群在P53诱导方面存在显著差异。照射后CD_4~+T、CD_8~+T和B细胞中P53的诱生作用显著。相反,TCR-γ/Delta^+T细胞和NK细胞均未显示出可识别的P53水平。这些结果表明,辐射诱导的淋巴细胞凋亡可能是由p53依赖或非依赖的机制介导的。
英文摘要
We employed EBV-induced infectious mononucleosis (IM) as a model of activated T cell death to elucidate cellular requirements for induction of T cell death by activation with viral infection. Obtained results are as follows :1)Both activated T cells in acute IM patients and memory T cells in normal persons express CD45RO and Fas antigen, which can mediate apoptosis. Unlike memory T cells, activated T cells in IM easily undergo apoptotic cell death after on a simple incubation in vitro. By immunizing mice with IM cells, we obtained a novel mouse monoclonal antibody, termed IMN3.1, which was marked to react with apoptosis-prone T cells. Molecular cloning of IMN3.1-identified antigen is in progress.2)Seemingly supporting their susceptibility to apoptosis, activated T cells in IM lacked expression of Bcl-2, which have a preventive function against apoptotic cell death. Low or absent expression of Bcl-2 was observed on granulocytes and monocytes, both of which have shorter life-spans. The important finding was that anti-Fas antibody could accelerated apoptotic cell death in granulocytes and monocytes. These observations suggest that the Fas antigen/ligand system may play a key role in resolution of inflammatory and immune responses.3)The mutation of the p53 oncogene is thought to lead to oncogenosis in human malignancies. Expression of p53 was not found in activated T cells in IM patients, although they were sucseptible to apoptosis. Ionizing irradiation could induce p53 expression on the whole population of peripheral blood lymphocytes, concomitant with marked apoptosis. However, we found a marked difference of lymphocyte subpopulations regarding p53 induction. Induction of p53 in CD4^+ T,CD8^+ T and B cells after irradiation was prominent. In contrast, neither TCR-gamma/delta^+ T cells nor NK cells showed identifiable levels of p53. The results suggest that radiation-induced lymphocytic apoptosis may be mediated by p53-dependent or-independent mechanisms.
期刊论文(58)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hashimoto,H.et al.: "The relationaship between serum levels of interleukin-6 and thyroid hormore in children with acute resproratory infection." J.Clin.Endocrinol.Metab.78. 288-291 (1994)
Hashimoto, H.et al.:“急性呼吸道感染儿童血清白细胞介素 6 水平与甲状腺激素水平之间的关系。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tsui,Takao: "Efficient induction of immunoglobulin production in neonatal naive B cells by memory CD4^+T cell subset expressing homing receptor L-selectin" Journal of Immunology. (掲載予定).
Tsui,Takao:“通过表达归巢受体 L-选择素的记忆 CD4^+T 细胞子集有效诱导新生儿幼稚 B 细胞中免疫球蛋白的产生”《免疫学杂志》(待出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Uehara,T.et al.: "A novel T-cell activation antigen identified by monoclonal IMN3.1 antibody and expressed preferentially on human T cells susceptible to apoptotic cell death." J.Immunol.150. 3243-3253 (1993)
Uehara,T.et al.:“一种由单克隆 IMN3.1 抗体鉴定的新型 T 细胞激活抗原,并优先在易受细胞凋亡影响的人类 T 细胞上表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tamaru,Y.et al.: "Absence of bcl-2 expression by activated CD45RO^+T lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death" Blood. 82. 521-527 (1993)
Tamaru,Y.et al.:“急性传染性单核细胞增多症中激活的 CD45RO^T 淋巴细胞不表达 bcl-2,支持其对程序性细胞死亡的易感性”血液。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hasui, M.et al.: "Mature helper T cell requirement for immunoglobulin production by neonatal naive B cells injected intraperitoneally into severe combined immunodeficient (SCID) mice." Clin.Exp.Immunol.Vol.95. 357-361 (1994)
Hasui, M.等人:“将新生幼稚 B 细胞腹膜内注射到严重联合免疫缺陷 (SCID) 小鼠中,以产生免疫球蛋白,需要成熟的辅助 T 细胞。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 25 条
Functional maturation of regulatory T cells during child growth and their disorders
-
批准号:20390294
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2008
-
负责人:MIYAWAKI Toshio
-
依托单位:
Study on rapid diagnosis of primary immunodeficiency diseases and their abnormalities in immunologic development
-
批准号:13307025
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$6.41万
-
财政年份:2001
-
负责人:MIYAWAKI Toshio
-
依托单位:
Study on rapid diagnosis and B cell defect of X-linked agammaglobulinemia
-
批准号:10470176
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.38万
-
财政年份:1998
-
负责人:MIYAWAKI Toshio
-
依托单位:
Functional Characteristics of Neonatal Naive T cell and Their Maturation into Memory T cell
-
批准号:02454268
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.2万
-
财政年份:1990
-
负责人:MIYAWAKI Toshio
-
依托单位:
国内基金
海外基金
登录
查看更多内容
EB病毒核抗原1通过靶向PPP1CA稳定自身表达及其调控EBV潜伏感染的作用和机制研究
-
批准号:2026JJ50144
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:卢建红
-
依托单位:
EBV-RBM4通过稳定HOXB13 mRNA促进鼻咽癌细胞上皮-间质转化及恶性进展
-
批准号:2026JJ81710
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈志
-
依托单位:
EBV上调E3连接酶RNF114抑制鼻咽癌细胞Necroptosis机制研究
-
批准号:2026JJ81963
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘文斌
-
依托单位:
EBV-miR-BART19-3p抑制GADD45B增强cyclinB1/CDK1结合促进EBV相关胃癌细胞增殖的机制研究
-
批准号:2025JJ81046
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:阳静
-
依托单位:
聚合物分子刷激动剂调控三级淋巴组织丰度预防 EBV感染
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于VSV的新型多价EBV疫苗研发及保护
机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:孔祥炜
-
依托单位:
EBV高危亚型编码的BALF2-HR蛋白上调HLA-II类分子促进鼻咽癌免疫逃逸的机制研究
-
批准号:2025JJ60152
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:葛军尚
-
依托单位:
EBV诱导鼻咽癌免疫治疗抵抗的作用及其
机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:杨琦
-
依托单位:
PI3K 抑制剂抑制EBV阳性淋巴瘤的分子机制研究
-
批准号:JCZRLH202500224
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
Vdelta2-T细胞外泌体疫苗携带IFN-gamma和TNF-alpha诱导抗原提呈细胞成熟并促进EBV肿瘤免疫应答的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王系伟
-
依托单位: